Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crofelemer for Diarrhea-Predominant IBS in Females
NCT00461526Phase 2Completed
- Sponsor
- Valeant Pharmaceuticals
- Start
- Oct 2006
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of crofelemer in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Valeant Pharmaceuticals. Started Oct 2006; status: completed.
02
Drugs
crofelemer
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT00461526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00461526.